menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Angiogenetic Therapies for Cancer Treatment

close
Angiogenetic Therapies for Cancer Treatment
Restart
Resume
Choose a format
Media formats available:
Details
Presenters
Comments
  • Overview

    In 1971 Dr. Judah Folkman announced to the world that angiogenesis would be the Achilles heel of cancer-what's happened in the last 35 years?  Dr. Walter M. Stadler, professor of medicine, director of Genitourinary Program, and associate dean of Clinical Research at the University of Chicago Medical Center joins host Dr. Bruce Bloom to fast forward from that early discovery to the current cutting edge uses for Avastin and other anti-angiogenics in cancer, including successes and shortcomings of this class of drugs in treating both solid tumors and blood cancers .   

Facebook Comments

Recommended
Details
Presenters
Comments
  • Overview

    In 1971 Dr. Judah Folkman announced to the world that angiogenesis would be the Achilles heel of cancer-what's happened in the last 35 years?  Dr. Walter M. Stadler, professor of medicine, director of Genitourinary Program, and associate dean of Clinical Research at the University of Chicago Medical Center joins host Dr. Bruce Bloom to fast forward from that early discovery to the current cutting edge uses for Avastin and other anti-angiogenics in cancer, including successes and shortcomings of this class of drugs in treating both solid tumors and blood cancers .   

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 8/7/20